Nav: Home

Drinking more water does not slow decline of kidney function for kidney disease patients

May 08, 2018

A new study, published in JAMA (Journal of the American Medical Association) by researchers at Lawson Health Research Institute and Western University, found that coaching patients with Chronic Kidney Disease (CKD) to drink more water does not slow down the decline of their kidney function.

"Despite widespread beliefs, little scientific data exists on the optimal amount of water to drink," explains Dr. William Clark, Scientist at Lawson and Professor at Western's Schulich School of Medicine & Dentistry. "While many claims about the benefits of increased water intake remain untested, a growing body of evidence suggests that increased water intake improves kidney function through the suppression of the antidiuretic hormone."

This leads to the question of whether increased water intake can slow the progressive loss of kidney function.

Guided by a successful pilot study, the research team constructed a randomized clinical trial with patients at London Health Sciences Centre (LHSC) and several other hospitals in Ontario. They wanted to determine if coaching patients to drink more water slowed their decline in kidney function over one year compared with those in the control group who were coached to maintain usual fluid intake.

"It is really about personalized medicine," says Dr. Clark who is the principal investigator for the study and Director of Apheresis and Consultant Nephrologist at LHSC. "Could we look at the general population of patients with kidney disease and find that increased water intake helps slow the decline in function? And if not, how can we apply this knowledge to create more targeted treatment approaches?"

The trial is the largest to date with over 630 participants with Stage 3 CKD. The cause of their disease was varied, including diabetes and high blood pressure.

"Those diagnosed with CKD have some degree of kidney damage, indicated by a decreased level of kidney function," explains Kerri Gallo, RN Project Manager for the study. "Kidney disease can range from mild to severe and, in some cases, leads to kidney failure. Kidney disease often starts slowly and develops without symptoms over a number of years, so it may not be detected until it has progressed to the point where kidney function is quite low."

Most patients with Stage 3 CKD experience either no symptoms or only mild effects, but they have already lost over 40 to 70 per cent of kidney function.

"Current treatment guidelines are very limited for these patients. It includes the use of medication and optimal blood pressure control including salt restriction and increased water intake," notes Gallo. "We have no way to actively stop the decline or regain function. Our efforts right now are to slow the progress."

The research team found that after one year, the increase of water did not slow the loss of kidney function. They did find that an increase of water, particularly when the participant's previous intake was low, did significantly suppress their antidiuretic hormone release. The prior benefits shown for water intake may relate to low water drinkers in the population.

"This research indicates that for most patients with CKD, increasing fluid intake will not stop further loss of kidney function. It does allow us then to focus our efforts on other potential therapeutic options," says Dr. Clark. "We do know that many patients are drinking well below the recommended amounts. More research is needed, but the goal would be to tailor increased water intake as a treatment to those patients."

The hope is to increase the personalized options of effective treatments available in order to reduce the risk of progression to kidney disease.
-end-
ABOUT WESTERN

Western delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.

ABOUT THE SCHULICH SCHOOL OF MEDICINE & DENTISTRY

The Schulich School of Medicine & Dentistry at Western University is one of Canada's preeminent medical and dental schools. Established in 1881, it was one of the founding schools of Western University and is known for being the birthplace of family medicine in Canada. For more than 130 years, the School has demonstrated a commitment to academic excellence and a passion for scientific discovery.

ABOUT LAWSON HEALTH RESEARCH INSTITUTE

As the research institute of London Health Sciences Centre and St. Joseph's Health Care London, and working in partnership with Western University, Lawson Health Research Institute is committed to furthering scientific knowledge to advance health care around the world.

Lawson Health Research Institute

Related Kidney Disease Articles:

Genes tell a story about diabetic kidney disease
Studying Finnish genes leads to unique revelations about the development of a serious complication of diabetes, and informs an ongoing genomic study of a Singaporean cohort as part of Singapore's Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO).
New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.
Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).
A healthy diet may help prevent kidney disease
In an analysis of published studies, a healthy dietary pattern was associated with a 30% lower incidence of chronic kidney disease.
Is kidney failure a man's disease?
A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.
Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.
Revealed: 35 kidney genes linked to chronic kidney disease risk
An international study lead by University of Manchester scientists has discovered the identity of genes that predispose people to chronic kidney disease.
Gene editing possible for kidney disease
For the first time scientists have identified how to halt kidney disease in a life-limiting genetic condition, which may pave the way for personalised treatment in the future.
In kidney disease patients, illicit drug use linked with disease progression and death
Among individuals with chronic kidney disease, hard illicit drug use was associated with higher risks of kidney disease progression and early death.
Drinking more water does not slow decline of kidney function for kidney disease patients
A new study, published in JAMA by researchers at Lawson Health Research Institute and Western University, found that coaching patients with Chronic Kidney Disease (CKD) to drink more water does not slow down the decline of their kidney function.
More Kidney Disease News and Kidney Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.